广发纳斯达克生物科技人民币(001092)

动态评分: 5.30分

投资组合

报告日期 名称 比例
2023-12-31 Adaptive Biotechnologies Corp 0.07%
2023-12-31 Icosavax Inc 0.07%
2023-12-31 ALX Oncology Holdings Inc 0.07%
2023-12-31 MacroGenics Inc 0.06%
2023-12-31 Fusion Pharmaceuticals Inc 0.06%
2023-12-31 Tarsus Pharmaceuticals Inc 0.06%
2023-12-31 Vera Therapeutics Inc-A 0.06%
2023-12-31 Savara Inc 0.06%
2023-12-31 Travere Therapeutics Inc 0.06%
2023-12-31 Evolus Inc 0.06%
2023-12-31 Bicycle Therapeutics Ltd ADR 0.06%
2023-12-31 Edgewise Therapeutics Inc 0.06%
2023-12-31 Kiniksa Pharmaceuticals Ltd-A 0.06%
2023-12-31 Alector Inc 0.06%
2023-12-31 Avidity Biosciences Inc 0.06%
2023-12-31 Tourmaline Bio Inc 0.05%
2023-12-31 Enliven Therapeutics Inc 0.05%
2023-12-31 Phathom Pharmaceuticals Inc 0.05%
2023-12-31 Cogent Biosciences Inc 0.05%
2023-12-31 Castle Biosciences Inc 0.05%

投资模拟

公告&资料